COVID-19 among fit patients with CLL treated with venetoclax-based combinations

This publication has 14 references indexed in Scilit:

• Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
  Leukemia Research, 2020
• Estimates of the severity of coronavirus disease 2019: a model-based analysis
  The Lancet Infectious Diseases, 2020
• The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
  Blood, 2020
• An interactive web-based dashboard to track COVID-19 in real time
  The Lancet Infectious Diseases, 2020
• COVID-19 in a patient with chronic lymphocytic leukaemia
  The Lancet Haematology, 2020
• Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
  European Respiratory Journal, 2020
• Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment
  Blood Advances, 2019
• Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study
  Haematologica, 2018
• Perturbation of the normal immune system in patients with CLL
  Blood, 2015
• T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
  Blood, 2013